Zečkanović, A., Maver, A., Ristić, S., Starčević Čizmarević, N., Peterlin, B. & Lovrečić, L. (2021). Potential protective role of a NOD2 polymorphism in the susceptibility to multiple sclerosis is not associated with interferon therapy. Biomedical Reports, 15. (6), 1-5. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:471732
Zečkanović, Aida, et al. "Potential protective role of a NOD2 polymorphism in the susceptibility to multiple sclerosis is not associated with interferon therapy." Biomedical Reports, vol. 15, no. 6, 2021, pp. 1-5. https://urn.nsk.hr/urn:nbn:hr:184:471732
Zečkanović, Aida, Aleš Maver, Smiljana Ristić, Nada Starčević Čizmarević, Borut Peterlin and Luca Lovrečić. "Potential protective role of a NOD2 polymorphism in the susceptibility to multiple sclerosis is not associated with interferon therapy." Biomedical Reports 15, no. 6 (2021): 1-5. https://urn.nsk.hr/urn:nbn:hr:184:471732
Zečkanović, A., et al. (2021) 'Potential protective role of a NOD2 polymorphism in the susceptibility to multiple sclerosis is not associated with interferon therapy', Biomedical Reports, 15(6), pp. 1-5. Available at: https://urn.nsk.hr/urn:nbn:hr:184:471732 (Accessed 03 December 2024)
Zečkanović A, Maver A, Ristić S, Starčević Čizmarević N, Peterlin B, Lovrečić L. Potential protective role of a NOD2 polymorphism in the susceptibility to multiple sclerosis is not associated with interferon therapy. Biomedical Reports [Internet]. 2021 [cited 2024 December 03];15(6):1-5. Available at: https://urn.nsk.hr/urn:nbn:hr:184:471732
A. Zečkanović, A. Maver, S. Ristić, N. Starčević Čizmarević, B. Peterlin and L. Lovrečić, "Potential protective role of a NOD2 polymorphism in the susceptibility to multiple sclerosis is not associated with interferon therapy", Biomedical Reports, vol. 15, no. 6, pp. 1-5, 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:471732. [Accessed: 03 December 2024]